While IKZF3 is associated with a higher risk in the TCGA melanoma cohort (Table 4, Supplementary Table S4), it also correlates with treatment response in MEL_PROG and VALID_PROG (Figure 3 and Figure 4). The gene discussed is IKZF3; the disease is melanoma.